Author

Dennis Kinyua

Memorial Sloan Kettering Cancer Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Alister P. W. FunnelliD· 1 shared Àlvaro Quintanal-VillalongaiD· 1 shared Andrea ArfèiD· 1 shared Arielle ElkriefiD· 1 shared Barbara Vaz de MelloiD· 1 shared Charles M. RudiniD· 1 shared Corrin A. WohlhieteriD· 1 shared Daniel BatesiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alister P. W. FunnellORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

SMARCA4, STK11, and KEAP1 co-inactivation associates with poor prognosis and upregulation of the TGF-β pathway in lung adenocarcinoma

Emily A. Costa, Barbara Vaz de Mello, Corrin A. Wohlhieter, Subhiksha Nandakumar, Samuel Tischfield, Yingqian Ada Zhan, Harsha Sridhar, Dennis Kinyua, Elisa de Stanchina, Wenfei Kang, Ning Fan, Alister P. W. Funnell, John E. Lazar, Justin Jee, Irina Linkov, , Charles M. Rudin

The paper identifies SMARCA4/STK11/KEAP1 triple mutant lung adenocarcinoma as a poor prognosis subset and links it to TGF-β pathway activation.

Translational Oncology · Jul 20, 2026Peer-reviewedCancer Biology